Axol Biosciences

Exhibition Partner

At Axol Biosciences, we’re here to support drug discovery researchers who want to harness the power of iPSC-derived models. Like you, we believe that these more human-relevant advanced in vitro models have the potential to unlock better, safer therapies for neurodegenerative and cardiovascular diseases. We offer a high-throughput screening services for dry AMD drug discovery using well characterized iPSC-derived retinal pigment epithelial cells.

For more information visit:

www.axolbio.com